Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab.

Siegel, Jacob D; Bhatia, Aarti; Ko, Christine J; Christensen, Sean R

Siegel, Jacob D; Bhatia, Aarti; Ko, Christine J; Christensen, Sean R.

Afiliação

Siegel JD; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Bhatia A; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut.
Ko CJ; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Christensen SR; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

JAAD Case Rep ; 18: 23-25, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34778502

Palavras-chave

PD-1; SCC; cSCC; cSCC, cutaneous squamous cell carcinoma; cemiplimab; cutaneous squamous cell carcinoma; immune checkpoint inhibitor; immunotherapy; locally advanced; metastatic; nontarget; programmed death-ligand 1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article